Skip to main content
SpringerLink
Log in

Holmium laser—induced coronary thrombolysis

  • Frontiers in Thrombocardiology
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Conclusions

Plaque disruption and thrombosis are determinants for the onset of acute ischemic syndromes. The presence of intracoronary thrombus is associated with an increased risk of complications during revascularization with balloon angioplasty. Thrombi avidly absorb light in the mid-infrared optical spectrum due to their high water content. The potential clinical advantages of the holmium laser as a source of thrombolysis include rapid removal of the target clot, vaporization of procoagulant reactants, elimination of a systemic lytic state, and facilitation of adjunct balloon angioplasty by concomitant plaque vaporization. Notably, while thrombolytic drug therapy treats only the acute cause, that is, thrombus, the laser has the potential for treating both thrombus and its underlying cause, that is, the atherosclerotic plaque. In vitro studies suggest that the effect of the holmium laser is achieved by nonselective, mechanical disruption of the irradiated thrombus, a mechanism unlike selective thrombolysis as induced by pulsed-dye lasers. Further basic and clinical research is needed to explore holmium laser-thrombus interactions and thus lead to optimal clinical application of this technology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Falk E. Coronary thrombosis: Pathogenesis and clinical manifestations. Am J Cardiol 1991;68:28B-35B.

    Google Scholar 

  2. Chesebro JH, Fuster V. Thrombosis in unstable angina. N Engl J Med 1992;327:192–194.

    Google Scholar 

  3. Maseri A, Chierchia S, Davies G. Pathophysiology of coronary occlusion in acute infarction. Circulation 1986;73:233–239.

    Google Scholar 

  4. Kennedy JW, Ritchie JL, Davies KB, Stadius ML, Maynard C, Fritz JK. Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 1983;309:1477–1482.

    Google Scholar 

  5. Topol EJ. Thrombolytic Intervention. In: Topol EJ, ed. Textbook of Interventional Cardiology, 1st ed. Philadelphia: WB Saunders, 1990:76–120.

    Google Scholar 

  6. Rothbaum D, Linnemeyer TJ, Landin RJ, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: A 3 year experience. J Am Coll Cardiol 1987;10:264–272.

    Google Scholar 

  7. Safian RD, Grines CL, May MA, et al. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts. Circulation 1994;89:302–312.

    Google Scholar 

  8. Steffen W, Fishbein MC, Luo H, et al. High intensity, low frequency catheter-delivered ultrasound dissolution of occlusive coronary artery thrombi: An in vitro and in vivo study. J Am Coll Cardiol 1994;24:1571–1579.

    Google Scholar 

  9. Carrel T, Jenni R, Hanbold-Renter S, von Schulters G, Pasic M, Turina M. Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothorac Surg 1992;6:478–484.

    Google Scholar 

  10. Topaz O. Coronary laser angioplasty. In: Topol EJ, ed. Textbook of Interventional Cardiology, 2nd ed.Philadelphia: WB Saunders, 1995:235–255.

    Google Scholar 

  11. Gregory KW. Laser thrombolysis. In: Topol EJ, ed., Textbook of Interventional Cardiology. 2nd ed. Philadelphia: WB Saunders, 1993:892–902.

    Google Scholar 

  12. ISIS-3. A randomized comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin alone among 41,299 cases of suspected acute myocardial infarction. Lancet 1992;339:753–770.

    Google Scholar 

  13. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349–360.

    Google Scholar 

  14. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397–402.

    Google Scholar 

  15. GISSI-2: A factorial randomized trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet 1990;336:65–71.

    Google Scholar 

  16. Schroder R, Neuhaus K-L, Leizorovics A, et al. A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): Long term mortality and morbidity. J Am Coll Cardiol 1987;91:197–203.

    Google Scholar 

  17. Wilcox RG, Olsson CG, Skene AM, von der Lippe G, Jensen G, Hampton JR for the ASSET Study Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet 1988;1:525–530.

    Google Scholar 

  18. Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group. Lancet 1988;1:545–549.

    Google Scholar 

  19. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270:1211–1216.

    Google Scholar 

  20. The GUSTO Angiographic investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329:1615–1622.

    Google Scholar 

  21. Cigarroa RG, Lange RA, Hillis LD. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow. Am J Cardiol 1989;64:155–160.

    Google Scholar 

  22. Doorey AJ, Michelson EL, Weber FJ, Dreifus LS. Thrombolytic therapy of acute myocardial infarction: Emerging challenges of implementation. J Am Coll Cardiol 1987;10:1357–1360.

    Google Scholar 

  23. Grines CL, DeMaria AN. Optimal utilization of thrombolytic therapy for acute myocardial infarction: Concepts and controversies. J Am Coll Cardiol 1990;16:223–231.

    Google Scholar 

  24. Muller DWM, Topol EJ. Selection of patients with acute myocardial infarction for thrombolytic therapy. Ann Intern Med 1990;113:949–960.

    Google Scholar 

  25. LATE Study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6–24 hours after onset of acute myocardial infarction. Lancet 1993;342:759–766.

    Article  PubMed  Google Scholar 

  26. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Lancet 1994;343:311–322.

    Google Scholar 

  27. O'Neil WW, Brodie B, Ivanhoe R, et al. Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry). Am J Cardiol 1994;73:627–634.

    Google Scholar 

  28. Eckman MH, Wong JB, Slem DN, et al. Direct angioplasty for acute myocardial infarction. A review of outcomes in clinical subsets. Ann Intern Med 1992;117:667–676.

    Google Scholar 

  29. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673–679.

    Google Scholar 

  30. Topaz O. Plaque removal and thrombus dissolution with pulsed-wave lasers' photoacoustic energy—biotissue interactions and their clinical manifestations. Cardiology 1996, in press.

  31. Abela GS, Barbeau GR. Laser angioplasty: Potential effects and current limitations. In: Topol EJ, ed. Textbook of Interventional Cardiology, 1st ed. Philadelphia: WE Saunders, 1990:724–737.

    Google Scholar 

  32. Topaz O, Morris C, Minisi AJ, Mohanty PK, Carr ME Jr. Photoacoustic fibrinolysis: Pulsed-wave, mid-infrared, laser-clot interaction. J Thromb Thromboly 1996;3:209–214.

    Google Scholar 

  33. Topaz O. Solid-state laser: The holmium: YAG system. In: Ellis SG, Holmes DR Jr, eds. Strategic Approaches in Coronary Intervention. Baltimore, MD: Williams & Wilkins, 1995:50–63.

    Google Scholar 

  34. Davis MJ, Thomas AC. Plaque fissuring: The cause of acute myocardial infarction causing sudden ischemic death and crescendo angina. Br Heart J 1985;53:363–373.

    Google Scholar 

  35. Friedman M, van den Boverkamp GJ. The pathogenesis of a coronary thrombus. Am J Pathol 1966;80:19–44.

    Google Scholar 

  36. Vetrovec GW, Cowley MJ, Overton H, Richardson D. Intracoronary thrombus in syndromes of unstable myocardial ischemia. Am Heart J 1981;102:1202–1208.

    Google Scholar 

  37. Estella P, Ryan T, Landzberg JS, Bittl JA. Excimer laserassisted coronary angioplasty for lesions containing thrombus. J Am Coll Cardiol 1993;21:1550–1556.

    Google Scholar 

  38. Topaz O, Rozenbaum EA, Schumacher A, Luxenberg MG. Solid-state mid-infrared laser facilitated coronary angioplasty: Clinical and quantitative coronary angiographic results in 112 patients. Lasers Surg Med 1996, in press.

  39. Geschwind HJ, Nakamura F, Kvasnicka J. Laser angioplasty: Present and future. In: Ginsburg R, Geschwind HJ, eds. Primer on Laser Angioplasty, 2nd ed. Mount Kisco, NY: Futura, 1992:159–170.

    Google Scholar 

  40. Topaz O. A new, safer lasing technique for laser-facilitated coronary angioplasty. J Intervent Cardiol 1993;6:297–306.

    Google Scholar 

  41. DeMarchena E, Mallon S, Posada JD, et al. Direct holmium laser-assisted balloon angioplasty in acute myocardial infarction. Am J Cardiol 1993;71:1223–1225.

    Google Scholar 

  42. Topaz O. Holmium laser coronary thrombolysis: A new treatment modality for revascularization in acute myocardial infarction. J Clin Laser Med Surg 1992;10:427–431.

    Google Scholar 

  43. Topaz O, Rozenbaum E, Battista S, Peterson C, Wysham D. Laser facilitated angioplasty in acute myocardial infarction complicated by prolonged or recurrent chest pain. Cathet Cardiovasc Diagn 1993;28:7–16.

    Google Scholar 

  44. Topaz O, Vetrovec GW. Laser for optical thrombolysis and facilitation of balloon angioplasty following failed pharmacologic thrombolysis. Cathet Cardiovasc Diagn 1995;36:38–42.

    Google Scholar 

  45. Topaz O, Minisi AJ, Luxenberg M, Rozenbaum E. Laser angioplasty for lesions unsuitable for PTCA in acute myocardial infarction: Quantitative coronary angiography and clinical results. Circulation 1994;90(Suppl I):I434.

    Google Scholar 

  46. Lee G, Ikeda RM, Strobbe D. Effect of laser irradiation on human thrombus: Demonstration of a linear dissolution-dose relation between clot length and energy density. Am J Cardiol 1983;52:876–877.

    Google Scholar 

  47. Abela GS, Picon PD, Friedl SE, et al. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation 1995;91:776–784.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia, USA

    On Topaz

Authors
  1. On Topaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Topaz, O. Holmium laser—induced coronary thrombolysis. J Thromb Thrombol 3, 327–330 (1996). https://doi.org/10.1007/BF00133075

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00133075

Keywords

Search

Navigation